Los Alamos National LaboratoryBiosurveillance Gateway
Diagnostics, predictive modelling, and decision support for global and national security

Biosurveillance in Action

Los Alamos National Laboratory is applying biosurveillance expertise to the COVID-19 pandemic.

Contact Us  

  • Media Contact
  • Nancy Ambrosiano
  • (505) 699-1149
  • Email
  • National Security and Defense Program Office
  • Kirsten Taylor-McCabe
  • (505) 665-0634
  • Email

Current COVID-19 Projects

Diagnostics and Genomics

  • Using genomics to validate publicly available SARS-CoV-2 assays and to identify why some produce false negatives. COVID-19 Genome Analytics website
  • FDA-CLIA registered COVID-19 testing facility to support surge capacity diagnostic testing.
  • Developing high-affinity antibody pairs for advanced diagnostic tools.
  • Testing several commercially available and lab-made viral transport media to facilitate the testing supply chain.
  • Providing bioinformatics expertise and support to partner labs worldwide that are processing COVID-19 samples in their own countries.
  • Developing new tests that could screen for multiple respiratory pathogens at once.

Predictive Modeling

  • Forecasting Confirmed Cases and Deaths for COVID-19. COVID-19 Forecasted Case Data website 
  • Quantifying how the SARS-CoV-2 virus behaves in the host organism.
  • Using bioinformatics and modeling to track the diversity of the pathogen and how it is evolving in the pandemic.

Decision Support

  • Developing models of various mitigation strategies to inform decision makers.
  • Modeling hospital/healthcare surge capacity in response to COVID-19.
  • Using models to evaluate critical healthcare supply chains.

Vaccines and Countermeasures

  • Developing a T-cell response vaccine for SARS-CoV-2.
  • Investigating the interaction between SARS-CoV-2 and human receptors to develop lung-protective therapies.
  • Design and synthesis of surface proteins for drug studies.
  • Synthesis of anti-viral drugs for the treatment of COVID-19.
  • Structural and computational identification of potential drug targets. 

 Submit a request to learn more about LANL capabilities or to contact scientists